1. Central Brain Tumor Registry of the United States: CBTRUS 2002–2003. Statistical Report: Primary Brain Tumors in the United States, 1995–1999. Chicago: CBTRU; 2002.
2. Levin VA, Leibel SA, Gutin PH: Neoplasms of the central nervous system. In Cancer: Principles & Practice of Oncology, edn 6. Edited by De Vita VT, Hellman S, Rosenberg SA. Philadelphia: Lippincott Williams & Wilkins; 2001:2100–2103.
3. Dinnes J, Cave C, Huang S, Milne R: A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma. Br J Cancer 2002, 86:501–505.
4. Yung WY, Prados MD, Yaya TR, et al.: Multicenter phase II trial of temozolomide in patients with anaplastic astrocytomas or anaplastic oligoastrocytoma at first relapse. J Clin Oncol 1999, 17:2762–2771.
5. Yung WY, Albright RE, Olson J, et al.: A phase II study of temozolomide vs procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 2000, 83:589–593.